Highline Wealth Partners
VRTX icon

Highline Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Highline Wealth Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$918K Buy
1,755
+16
+0.9% +$8.19K 0.17% 62
2026
Q2 		$864K Buy
1,739
+1,417
+440% +$628K 0.18% 60
2026
Q1 		$144K Buy
322
+297
+1,188% +$138K 0.04% 100
2025
Q4 		$11.3K Sell
25
-13
-34% -$5.6K ﹤0.01% 371
2025
Q3 		$14.9K Sell
38
-5
-12% -$2.09K ﹤0.01% 337
2025
Q2 		$19.1K Buy
43
+1
+2% +$461 0.01% 231
2025
Q1 		$20.4K Buy
42
+26
+163% +$12.1K 0.01% 204
2024
Q4 		$6.44K Sell
16
-43
-73% -$19.9K ﹤0.01% 300
2024
Q3 		$27.4K Buy
59
+48
+436% +$23.1K 0.01% 162
2024
Q2 		$5.16K Buy
11
+1
+10% +$434 ﹤0.01% 289
2024
Q1 		$4.18K Hold
10
– – ﹤0.01% 285
2023
Q4 		$4.07K Hold
10
– – ﹤0.01% 256
2023
Q3 		$3.48K Hold
10
– – ﹤0.01% 243
2023
Q2 		$3.52K Hold
10
– – ﹤0.01% 194
2023
Q1 		$3.15K Hold
10
– – ﹤0.01% 204
2022
Q4 		$2.89K Hold
10
– – ﹤0.01% 198
2022
Q3 		$2.9K Buy
+10
New +$2.88K ﹤0.01% 191

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Provident Investment Management
Provident Investment Management Novi, Michigan $999M AUM 19.45% 1-Year Est. Return

Highline Wealth Partners's VRTX Position: Q3 2026 in Review

Highline Wealth Partners increased its Vertex Pharmaceuticals (VRTX) stake by 0.92% in Q3 2026, buying an estimated $8.19K and bringing the position to 1,755 shares worth $918K. The position accounts for 0.17% of the portfolio, ranked #62.

Highline Wealth Partners first reported a position in VRTX in Q3 2022 and has held it in 17 quarters since. 478 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Highline Wealth Partners held 1,755 shares of Vertex Pharmaceuticals worth $918K as of Q3 2026.
  • Highline Wealth Partners bought 16 Vertex Pharmaceuticals shares in Q3 2026, an estimated $8.19K.
  • Vertex Pharmaceuticals made up 0.17% of Highline Wealth Partners's portfolio in Q3 2026, its #62 holding.
  • Highline Wealth Partners first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 17 quarters since.
  • 478 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.